about
Therapeutic interventions in severe asthmaIn Silico Prediction of T and B Cell Epitopes of Der f 25 in Dermatophagoides farinaeIntranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitisStratified approaches to the treatment of asthma.Molecular cloning, expression, IgE binding activities and in silico epitope prediction of Per a 9 allergens of the American cockroachDevelopments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy.Sublingual immunotherapy for allergic rhinitis and conjunctivitis.Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Specific immunotherapy in asthma: a comprehensive review.Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Allergen immunotherapy in asthma; what is new?Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.Food allergy from an avoidance to a proactive approach: a bridge too far?A prospective study on the safety of sublingual immunotherapy in pregnancy.Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.
P2860
Q28079238-F582B591-2AC1-4AD8-B075-84A8DE9A7D71Q33661465-D6E20E2A-4AF5-4B5C-82B3-492CD3BB56A8Q36830128-4A87695C-B23E-400B-8C5F-09C7BA0B6F41Q37064755-FD47B426-EB52-4AFD-8E62-7D2D667DF604Q37426652-CBEE222E-B9F3-46C2-866C-09F51D781BFAQ38062586-AAB04241-9023-4E8A-8997-8E26F27A30C0Q38085032-AC49E2E3-938A-40AD-8018-10995E35EA1CQ38149941-5E89BD46-47EE-4BBD-825F-0A206EEF8682Q38161996-BD2F6688-49D1-4BA5-A1D2-D2185E88141FQ38284820-59ECEAFF-8C78-4A37-A58E-16EAE1236696Q39037216-B1931A79-4DCA-48CC-BDF4-2FCDF8348988Q39038000-199C3FBB-B466-48D6-A2DD-007BAFB088D0Q39649421-A4DCDDE3-CCE8-4F37-8FAC-403780B6C654Q41981394-3E72D662-B472-4CB6-A246-C84D508C8AB8Q44298773-3F2E8FE6-650F-4626-806C-860EB1348859Q47098828-85702AAC-4401-4EC8-BDD5-3C0B2FA606FE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Specific immunotherapy in asthma: efficacy and safety.
@en
Specific immunotherapy in asthma: efficacy and safety.
@nl
type
label
Specific immunotherapy in asthma: efficacy and safety.
@en
Specific immunotherapy in asthma: efficacy and safety.
@nl
prefLabel
Specific immunotherapy in asthma: efficacy and safety.
@en
Specific immunotherapy in asthma: efficacy and safety.
@nl
P2860
P1476
Specific immunotherapy in asthma: efficacy and safety.
@en
P2860
P304
P356
10.1111/J.1365-2222.2010.03688.X
P577
2011-01-24T00:00:00Z